Skip to Content Skip to Content

Health Sciences

Reset All Filters
2001 Results
Want to Change the World? Penn Has a Prize for That

Want to Change the World? Penn Has a Prize for That

The big banner on the ARCH on Locust Walk and the emails from President Gutmann to the senior class have gotten the message out: The search for entries in the inaugural President’s Engagement Prize competition is underway.
See-Through, One-Atom-Thick, Carbon Electrodes are a Powerful Tool for Studying Epilepsy, Other Brain Disorders, Penn Study Finds

See-Through, One-Atom-Thick, Carbon Electrodes are a Powerful Tool for Studying Epilepsy, Other Brain Disorders, Penn Study Finds

Researchers from the Perelman School of Medicine and School of Engineering at the University of Pennsylvania and The Children's Hospital of Philadelphia have used graphene -- a two-dimensional form of carbon only one atom thick -- to fabricate a

Karen Kreeger

Penn Medicine Researchers Zero in on Psoriasis-Hypertension Link

Penn Medicine Researchers Zero in on Psoriasis-Hypertension Link

Patients with more severe psoriasis are also more likely to have uncontrolled hypertension, according to new research by a team at the Perelman School of Medicine at the University of Pennsylvania.

Katie Delach

Brain’s Compass Relies on Geometric Relationships, Say Penn Researchers

Brain’s Compass Relies on Geometric Relationships, Say Penn Researchers

The brain has a complex system for keeping track of which direction you are facing as you move about; remembering how to get from one place to another would otherwise be impossible. Researchers from the University of Pennsylvania have now shown how the brain anchors this mental compass.

Evan Lerner

Penn Medicine: New Gene Therapy for "Bubble Boy" Disease Appears to be Safe, Effective

Penn Medicine: New Gene Therapy for "Bubble Boy" Disease Appears to be Safe, Effective

A new form of gene therapy for boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a life-threatening condition also known as “bubble boy” disease, appears to be both effective and safe, according to an international clinical trial with sites in Boston, Cincinnati, Los Angeles, London, and Paris. 

Karen Kreeger

Penn Medicine's Basser Research Center for BRCA Announces $6.9 Million in New Grants to Further BRCA1 and BRCA2 Mutation Research

Penn Medicine's Basser Research Center for BRCA Announces $6.9 Million in New Grants to Further BRCA1 and BRCA2 Mutation Research

The University of Pennsylvania’s Basser Research Center for BRCA has announced $6.9 million to research teams both at Penn and at five other institutions across the United States, aimed at advancing the care of patients living with BRCA1 and BRCA2 mutations through multi-disciplinary collaboration.

Katie Delach